Internal Medicine · Canton, MS
NPI
1275543597
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
122 E Academy St
Canton, MS, 39046
Phone (601) 859-8992
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.1M
22,712 prescriptions
Company payments, 2025
$89.01
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug L C Tennin Jr. prescribed most often to Medicare patients was Amlodipine Besylate, with 954 prescriptions and refills. In total L C Tennin Jr. wrote 22,712 Medicare prescriptions that cost $2.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Amlodipine Besylate Generic | 954 | 2,086 | 245 | $4,946 |
| Atorvastatin Calcium Generic | 781 | 1,647 | 202 | $8,342 |
| Gabapentin Generic | 676 | 951 | 170 | $7,805 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 576 | 576 | 114 | $8,136 |
| Metformin Hcl Generic | 560 | 1,130 | 146 | $3,320 |
| Omeprazole Generic | 486 | 1,006 | 125 | $5,544 |
| Pantoprazole Sodium Generic | 394 | 701 | 106 | $3,954 |
| Hydrochlorothiazide Generic | 363 | 815 | 107 | $1,486 |
| Rosuvastatin Calcium Generic | 354 | 813 | 99 | $3,257 |
| Potassium Chloride Generic | 335 | 655 | 81 | $5,241 |
| Furosemide Generic | 327 | 605 | 88 | $1,564 |
| Losartan Potassium Generic | 308 | 651 | 74 | $3,426 |
| Januvia Sitagliptin Phosphate | 300 | 399 | 46 | $204K |
| Tamsulosin Hcl Generic | 275 | 510 | 65 | $3,274 |
| Eliquis Apixaban | 274 | 326 | 41 | $180K |
Brand drugs: 2,768 claims; generic drugs: 19,739 claims; opioid claims: 998.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid L C Tennin Jr. $89.01 ($89.01 in general payments such as food, travel and fees) from 2 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $72.07.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.